Optiver Holding
CALT

Optiver Holding’s Calliditas Therapeutics AB American Depositary Shares CALT Stock Holding History

Optiver Holding’s Portfolio CALT Stock Details CALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-22,336
Closed -$871K – 1129
2024
Q2 		$871K Buy
22,336
+19,802
+781% +$544K ﹤0.01% 435
2024
Q1 		$54.9K Buy
2,534
+1,554
+159% +$34.6K ﹤0.01% 541
2023
Q4 		$25.3K Buy
+980
New +$18.4K ﹤0.01% 438
2023
Q3 		– Sell
-5,030
Closed -$79K – 625
2023
Q2 		$79K Buy
5,030
+1
+0% +$21 ﹤0.01% 401
2023
Q1 		$120K Sell
5,029
-6,112
-55% -$122K ﹤0.01% 410
2022
Q4 		$195K Sell
11,141
-1,484
-12% -$23.9K ﹤0.01% 351
2022
Q3 		$191K Buy
12,625
+11,726
+1,304% +$204K ﹤0.01% 299
2022
Q2 		$16K Buy
899
+556
+162% +$9.69K ﹤0.01% 306
2022
Q1 		$6K Sell
343
-41,858
-99% -$839K ﹤0.01% 457
2021
Q4 		$1.04M Buy
42,201
+42,097
+40,478% +$845K ﹤0.01% 236
2021
Q3 		$2K Buy
+104
New +$2.85K ﹤0.01% 692

Other funds holding CALT

CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
AP
Advisors Preferred Rockville, Maryland $679M AUM 22.19% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
MTIC
Missouri Trust & Investment Company Springfield, Missouri $341M AUM 17.31% 1-Year Est. Return

Optiver Holding's CALT Position: Q3 2024 in Review

Optiver Holding sold out of Calliditas Therapeutics AB American Depositary Shares (CALT) in Q3 2024, closing a stake of 22,336 shares — an estimated $871K sold.

Optiver Holding first reported a position in CALT in Q3 2021 and held it in 11 quarters. The position peaked at $1.04M in Q4 2021. 5 funds tracked by Wall St. Rank hold CALT as of Q3 2024.

  • Optiver Holding reported no remaining Calliditas Therapeutics AB American Depositary Shares position as of Q3 2024 after selling out during the quarter.
  • Optiver Holding sold 22,336 Calliditas Therapeutics AB American Depositary Shares shares in Q3 2024, an estimated $871K.
  • Optiver Holding first reported a position in Calliditas Therapeutics AB American Depositary Shares in Q3 2021 and held it in 11 quarters.
  • Optiver Holding's Calliditas Therapeutics AB American Depositary Shares position peaked at $1.04M in Q4 2021.
  • 5 funds tracked by Wall St. Rank held Calliditas Therapeutics AB American Depositary Shares as of Q3 2024.

Based on Optiver Holding's 13F filing for Q3 2024, filed 14 Nov 2024.